跳至主要内容
临床试验/NCT06516159
NCT06516159已完成不适用

Validation of the MBI-C Scale in French

University Hospital, Toulouse5 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2023年6月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
170
试验地点
5
主要终点
Consistency for Internal validity of the Mild Behavioral Impairment-Checklist score

研究概览

简要总结

This study aims to validate the French version of the Mild Behavioral Impairment-Checklist (MBI-C) scale, hypothetically effective for measuring behavioral symptoms in patients presenting with a subjective cognitive complaint or mild cognitive impairment (MCI).

详细描述

Neuropsychiatric symptoms are common in the prodromal stage of dementia and may precede cognitive impairment. Their presence in patients without cognitive impairment, but with a subjective cognitive complaint or mild cognitive impairment (MCI), is associated with an increased risk of progression to dementia. The concept of Mild Behavioral Impairment (MBI) was developed to identify populations at risk from the early stages of the disease. MBI is characterized by long-lasting psychiatric symptoms appearing late, in patients without cognitive deficits or with MCI, and can precede dementia.

The general hypothesis is that the French version of the Mild Behavioral Impairment-Checklist (MBI-C) scale has good psychometric capabilities to correctly measure behavioral symptoms in patients with subjective cognitive complaint or MCI. The main objective is to verify the reliability and internal and external validity of the MBI-C score. Secondary objectives include studying the prevalence of MBI and determining the best cutoff for the diagnosis of MBI in patients with MBI or subjective cognitive complaint.

This is an observational, national, multicenter and cross-sectional study. It will include 170 patients (5 per scale item, or 34 items), with an inclusion period of 24 months and a total research duration of 25 months. Patients must be over 50 years old, have had subjective cognitive complaint or mild cognitive impairment for at least 6 months, and have a person who visits them at least once a week.

Validation of the MBI-C scale in French could play a crucial role in the identification and early management of neurodegenerative disorders.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient presenting a subjective cognitive complaint (SCP) or mild cognitive impairment (MCI) for at least 6 months.
  • Patient with a relative visiting them at least once a week.
  • No opposition from the patient and his loved one

排除标准

  • Patient presenting criteria for major neurocognitive disorder according to DSM-V criteria.
  • Neuropsychiatric symptoms secondary to concomitant treatments, or to a medical or psychiatric pathology.
  • Concomitant major depressive episode (DSM-V).
  • Presence of concomitant pathologies preventing participation in the study (taking tests).

结局指标

主要结局

Consistency for Internal validity of the Mild Behavioral Impairment-Checklist score

时间窗: Baseline

consistency will be assessed using Cronbach's alpha and McDonald's Omega coefficients.

External validation of the Mild Behavioral Impairment-Checklist score

时间窗: Baseline

Comparison of differences between the scores of the five domains of the NeuroPsychiatric Inventory-Total Questionnaire (NPI-Q) and the MBI-C.

次要结局

  • Prevalence of Mild Behavioral Impairment (MBI) in memory center patients presenting mild cognitive impairment (MCI) or a subjective cognitive complaint (SCC).(Baseline)
  • Determination of the best threshold for the diagnosis of Mild Behavioral Impairment (MBI) in patients with mild cognitive impairment (MCI) or subjective cognitive complaint (SCC).(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验